Zobrazeno 1 - 3
of 3
pro vyhledávání: '"John, Kark"'
Autor:
Claude Sagi, Hrayr G Basmajian, Harsh R. Parikh, Robert V O'Toole, John Kark, Brian Miller, Brian P. Cunningham, Austin Heare, Ashley Ali, Bradley Reahl, Saif U Zaman, Giuliana Rotuno, William T. Obremskey, David W. Shearer, Ryan McLemore, Mark Bender, Ryan N Montalvo, Breanna L Blaschke
Publikováno v:
European Journal of Orthopaedic Surgery & Traumatology. 31:235-243
Subtrochanteric femur fractures associate with a relatively high complication rate and are traditionally treated operatively with a period of limited weight bearing. Transitioning from extramedullary to intramedullary implants, there are increasing b
Autor:
Brian P, Cunningham, Ashley, Ali, Harsh R, Parikh, Austin, Heare, Breanna, Blaschke, Saif, Zaman, Ryan, Montalvo, Bradley, Reahl, Giuliana, Rotuno, John, Kark, Mark, Bender, Brian, Miller, Hrayr, Basmajian, Ryan, McLemore, David W, Shearer, William, Obremskey, Claude, Sagi, Robert V, O'Toole
Publikováno v:
European journal of orthopaedic surgerytraumatology : orthopedie traumatologie. 31(2)
Subtrochanteric femur fractures associate with a relatively high complication rate and are traditionally treated operatively with a period of limited weight bearing. Transitioning from extramedullary to intramedullary implants, there are increasing b
Publikováno v:
Journal of the National Medical Association. 95(8)
Imatinib mesylate (STI 571, Gleevec) is a potent bcr-abl tyrosine kinase inhibitor. It also inhibits c-kit tyrosine kinase. Imatinib mesylate is active in the treatment of cronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GIST). It i